Skip to main content
Heranba Industries Limited logo

Heranba Industries Limited — Investor Relations & Filings

Ticker · HERANBA ISIN · INE694N01015 LEI · 335800OPXIEPYCNRWS37 BSE.NS Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2022-05-16 Regulatory Filings
Country IN India
Listing BSE.NS HERANBA

About Heranba Industries Limited

https://www.heranba.co.in/

Heranba Industries Limited specializes in the manufacturing and marketing of synthetic pyrethroids and their intermediates. The company operates an integrated business model spanning the production of technicals, formulations, and branded products. Its extensive portfolio includes key active ingredients such as Cypermethrin, Deltamethrin, Alpha Cypermethrin, and Permethrin, catering to agriculture, public health, and animal health sectors. With multiple manufacturing facilities and dedicated R&D capabilities, the company provides a wide range of insecticides, herbicides, and fungicides. Heranba maintains a global footprint, supplying products to over sixty countries while ensuring quality control from intermediate stages to final crop protection solutions.

Recent filings

Filing Released Lang Actions
Newspaper Advertisements
Regulatory Filings Classification · 95% confidence The document is dated May 16, 2022, and references financial statements for the quarter and year ended March 31, 2022. It mentions the approval of financial results by the board of directors on May 14, 2022, and states that these financial statements have been published in newspapers. The document includes extracts of the newspaper publication of financial results, including key financial figures for the quarter and year ended March 31, 2022. The document is a formal communication to stock exchanges (BSE and NSE) informing them about the newspaper publication of the financial results. It does not contain the full detailed financial report itself but rather an announcement of the publication of the financial statements. The length of the document (15,000 characters) is substantial but the content is primarily an announcement and extract of published financial results, not the full report. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Regulatory Filing (RNS) because it is an official regulatory announcement about the publication of financial results, not the full Annual or Quarterly Report itself.
2022-05-16 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the availability of an audio recording of an earnings conference call discussing the audited financial results for the quarter and year ended March 31, 2022. It references the earnings call but does not contain the transcript itself or detailed financial data. The document is short (1172 characters) and primarily serves as an announcement that the audio recording is available on the company's website. According to the rules, announcements about earnings calls or reports without the actual content should be classified as Regulatory Filings (RNS) because it is a general regulatory announcement and does not contain the full transcript or financial data. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-05-15 English
Record Date
Regulatory Filings Classification · 95% confidence The document is a formal communication from the company to stock exchanges reporting the outcome of a Board Meeting held on May 14, 2022. It includes approval of financial results for the quarter and year ended March 31, 2022, along with the auditor's report. It also announces a recommended dividend, the date for the upcoming Annual General Meeting (AGM), record dates for dividend and AGM, and appointments of statutory, secretarial, cost, and internal auditors. The document is an announcement of decisions made by the Board rather than the full financial report itself. It references the financial results and auditor's report but does not contain the full financial statements or detailed financial analysis. The document length is about 5811 characters, which is relatively short and consistent with a regulatory announcement. Therefore, this document fits best under the category of Regulatory Filings (RNS) as it is a regulatory announcement of board meeting outcomes including financial results and appointments, not the full Annual Report or standalone Audit Report.
2022-05-14 English
Financial Result Updates
Annual Report Classification · 95% confidence The document is a detailed announcement from the Board of Directors of Heranba Industries Limited dated May 14, 2022. It includes the approval of financial results for the quarter and year ended March 31, 2022, along with the auditor's report. It also contains information about dividend declaration, the scheduling of the 30th Annual General Meeting, record dates, and appointments of statutory, secretarial, cost, and internal auditors. The document includes detailed financial data such as income, expenses, profit before tax, tax expenses, and earnings per share. The presence of comprehensive financial statements and auditor's report indicates this is a full financial report rather than a brief announcement or a certification. The document is not merely announcing the publication of a report but contains the actual financial results and related information. Therefore, this document fits the definition of an Annual Report (10-K) or a comprehensive financial report for the fiscal year. Given the detailed financial data and auditor's report, the classification as Annual Report (10-K) is appropriate.
2022-05-14 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the financial results for the fiscal year 2022 and the fourth quarter of FY22 for Heranba Industries Limited. It includes key financial highlights such as revenue, EBITDA, and profit after tax, along with management commentary. The document is concise (4517 characters) and formatted as a press release rather than a full detailed financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Annual Report (10-K) or Interim Report (IR). It is an initial announcement of quarterly and annual financial results, which fits the definition of an Earnings Release (ER). FY 2022
2022-05-14 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation Q4FY22 || May 2022' and contains detailed sections such as Company Overview, Management Team, Quarterly Performance, Financial Performance, and Strategy for Growth. It includes financial highlights for Q4FY22, quarterly and annual financial metrics, profit and loss summaries, balance sheet data, and business strategy information. The content is typical of a presentation prepared for investors to provide a comprehensive overview of the company's financials, operations, and outlook. There is no indication that this is a full annual report, audit report, or regulatory filing. The document is not a transcript, call, or voting announcement. It is a detailed presentation aimed at investors, consistent with the definition of an Investor Presentation (IP). The document length (15,000 characters) and detailed financial data support this classification with high confidence.
2022-05-14 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.